collection
Collections HericabMedicine

HericabMedicine

Artículos de Medicina interna

https://read.qxmd.com/read/34436727/chemotherapy-and-peripheral-neuropathy
#1
REVIEW
Tiffany Li, David Mizrahi, David Goldstein, Matthew C Kiernan, Susanna B Park
Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting side effect of many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome inhibitors, immunomodulatory drugs, and antibody-drug conjugates. The resultant symptoms often persist post treatment completion and continue to impact on long-term function and quality of life for cancer survivors. At present, dose reduction remains the only strategy to prevent severe neuropathy, often leading clinicians to the difficult decision of balancing maximal treatment exposure and minimal long-lasting side effects...
October 2021: Neurological Sciences
https://read.qxmd.com/read/34693519/guideline-for-the-laboratory-diagnosis-of-iron-deficiency-in-adults-excluding-pregnancy-and-children
#2
JOURNAL ARTICLE
Andrew Fletcher, Adam Forbes, Nicola Svenson, D Wayne Thomas
No abstract text is available yet for this article.
February 2022: British Journal of Haematology
https://read.qxmd.com/read/34630278/imaging-acute-stroke-from-one-size-fit-all-to-biomarkers
#3
REVIEW
Jianfei Lu, Qiyong Mei, Xianhua Hou, Anatol Manaenko, Lili Zhou, David S Liebeskind, John H Zhang, Yao Li, Qin Hu
In acute stroke management, time window has been rigidly used as a guide for decades and the reperfusion treatment is only available in the first few limited hours. Recently, imaging-based selection of patients has successfully expanded the treatment window out to 16 and even 24 h in the DEFUSE 3 and DAWN trials, respectively. Recent guidelines recommend the use of imaging techniques to guide therapeutic decision-making and expanded eligibility in acute ischemic stroke. A tissue window is proposed to replace the time window and serve as the surrogate marker for potentially salvageable tissue...
2021: Frontiers in Neurology
https://read.qxmd.com/read/34557164/common-pitfalls-in-the-interpretation-of-endocrine-tests
#4
REVIEW
Jose C Alvarez-Payares, Jesus David Bello-Simanca, Edwin De Jesus De La Peña-Arrieta, Jose Emilio Agamez-Gomez, Jhon Edwar Garcia-Rueda, Amilkar Rodriguez-Arrieta, Luis Antonio Rodriguez-Arrieta
Endocrine tests are the cornerstone of diagnosing multiple diseases that primary care physicians are frequently faced with. Some of these tests can be affected by situations that affect the proper interpretation, leading to incorrect diagnoses and unnecessary treatment, such as the interference of biotin with thyroid function test, falsely elevated prolactin values in presence of macroprolactinemia or falsely normal due to the "hook effect" in macroprolactinomas. Recognizing these situations is essential for the clinician to make an adequate interpretation of these tests as well as an accurate diagnosis that guarantees the best outcomes for the patient...
2021: Frontiers in Endocrinology
https://read.qxmd.com/read/33984268/venous-thromboembolism
#5
REVIEW
Faizan Khan, Tobias Tritschler, Susan R Kahn, Marc A Rodger
Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism, is a chronic illness that affects nearly 10 million people every year worldwide. Strong provoking risk factors for venous thromboembolism include major surgery and active cancer, but most events are unprovoked. Diagnosis requires a sequential work-up that combines assessment of clinical pretest probability for venous thromboembolism using a clinical score (eg, Wells score), D-dimer testing, and imaging. Venous thromboembolism can be considered excluded in patients with both a non-high clinical pretest probability and normal D-dimer concentrations...
July 3, 2021: Lancet
https://read.qxmd.com/read/33533874/differences-in-the-2020-esc-versus-2019-acc-aha-hrs-guidelines-on-atrial-fibrillation
#6
JOURNAL ARTICLE
Alireza Oraii, Ali Bozorgi, Masih Tajdini
No abstract text is available yet for this article.
May 14, 2021: European Heart Journal
https://read.qxmd.com/read/33104846/imaging-alternatives-to-colonoscopy-ct-colonography-and-colon-capsule-european-society-of-gastrointestinal-endoscopy-esge-and-european-society-of-gastrointestinal-and-abdominal-radiology-esgar-guideline-update-2020
#7
REVIEW
Cristiano Spada, Cesare Hassan, Davide Bellini, David Burling, Giovanni Cappello, Cristina Carretero, Evelien Dekker, Rami Eliakim, Margriet de Haan, Michal F Kaminski, Anastasios Koulaouzidis, Andrea Laghi, Philippe Lefere, Thomas Mang, Sebastian Manuel Milluzzo, Martina Morrin, Deirdre McNamara, Emanuele Neri, Silvia Pecere, Mathieu Pioche, Andrew Plumb, Emanuele Rondonotti, Manon Cw Spaander, Stuart Taylor, Ignacio Fernandez-Urien, Jeanin E van Hooft, Jaap Stoker, Daniele Regge
1. ESGE/ESGAR recommend computed tomographic colonography (CTC) as the radiological examination of choice for the diagnosis of colorectal neoplasia. Strong recommendation, high quality evidence. ESGE/ESGAR do not recommend barium enema in this setting. Strong recommendation, high quality evidence.2. ESGE/ESGAR recommend CTC, preferably the same or next day, if colonoscopy is incomplete. The timing depends on an interdisciplinary decision including endoscopic and radiological factors. Strong recommendation, low quality evidence...
May 2021: European Radiology
https://read.qxmd.com/read/32958591/cerebral-venous-thrombosis-a-practical-guide
#8
REVIEW
Leonardo Ulivi, Martina Squitieri, Hannah Cohen, Peter Cowley, David J Werring
All neurologists need to be able to recognise and treat cerebral venous thrombosis (CVT). It is difficult to diagnose, partly due to its relative rarity, its multiple and various clinical manifestations (different from 'conventional' stroke, and often mimicking other acute neurological conditions), and because it is often challenging to obtain and interpret optimal and timely brain imaging. Although CVT can result in death or permanent disability, it generally has a favourable prognosis if diagnosed and treated early...
October 2020: Practical Neurology
https://read.qxmd.com/read/33097308/hepatic-encephalopathy-novel-insights-into-classification-pathophysiology-and-therapy
#9
REVIEW
Christopher F Rose, Piero Amodio, Jasmohan S Bajaj, Radha Krishan Dhiman, Sara Montagnese, Simon D Taylor-Robinson, Hendrik Vilstrup, Rajiv Jalan
Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric abnormalities, from subclinical changes (mild cognitive impairment) to marked disorientation, confusion and coma. The clinical and economic burden of HE is considerable, and it contributes greatly to impaired quality of life, morbidity and mortality. This review will critically discuss the latest classification of HE, as well as the pathogenesis and pathophysiological pathways underlying the neurological decline in patients with end-stage liver disease...
October 20, 2020: Journal of Hepatology
https://read.qxmd.com/read/32998798/kdigo-2020-clinical-practice-guideline-for-diabetes-management-in-chronic-kidney-disease
#10
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
October 2020: Kidney International
https://read.qxmd.com/read/32990908/postoperative-diabetes-insipidus-how-to-define-and-grade-this-complication
#11
REVIEW
Friso de Vries, Daniel J Lobatto, Marco J T Verstegen, Wouter R van Furth, Alberto M Pereira, Nienke R Biermasz
PURPOSE: Although transient diabetes insipidus (DI) is the most common complication of pituitary surgery, there is no consensus on its definition. Polyuria is the most overt symptoms of DI, but can also reflect several physiological adaptive mechanisms in the postoperative phase. These may be difficult to distinguish from and might coincide with DI. The difficulty to distinguish DI from other causes of postoperative polyuria might explain the high variation in incidence rates. This limits interpretation of outcomes, in particular complication rates between centers, and may lead to unnecessary treatment...
April 2021: Pituitary
https://read.qxmd.com/read/32861308/gastric-cancer
#12
REVIEW
Elizabeth C Smyth, Magnus Nilsson, Heike I Grabsch, Nicole Ct van Grieken, Florian Lordick
Gastric cancer is the fifth most common cancer and the third most common cause of cancer death globally. Risk factors for the condition include Helicobacter pylori infection, age, high salt intake, and diets low in fruit and vegetables. Gastric cancer is diagnosed histologically after endoscopic biopsy and staged using CT, endoscopic ultrasound, PET, and laparoscopy. It is a molecularly and phenotypically highly heterogeneous disease. The main treatment for early gastric cancer is endoscopic resection. Non-early operable gastric cancer is treated with surgery, which should include D2 lymphadenectomy (including lymph node stations in the perigastric mesentery and along the celiac arterial branches)...
August 29, 2020: Lancet
https://read.qxmd.com/read/23436835/cancer-of-unknown-primary-sites-what-radiologists-need-to-know-and-what-oncologists-want-to-know
#13
REVIEW
Kyung Won Kim, Katherine M Krajewski, Jyothi P Jagannathan, Mizuki Nishino, Atul B Shinagare, Jason L Hornick, Nikhil H Ramaiya
OBJECTIVE: In this article, we review the role of imaging in cancer of unknown primary site (CUP) diagnosis and management and the utility of immunohistochemistry, serum tumor markers, and molecular profiling in the optimized care of CUP patients. CONCLUSION: With advances in imaging, pathology, and molecular medicine, the diagnosis and management of CUP have evolved into more personalized and site-specific therapies. A multidisciplinary integrated approach among oncologists, pathologists, and radiologists is extremely important...
March 2013: AJR. American Journal of Roentgenology
https://read.qxmd.com/read/33017826/peritoneal-dialysis-is-an-option-for-acute-kidney-injury-management-in-patients-with-covid-19
#14
REVIEW
José M Rodríguez-Chagolla, Enzo Vásquez Jiménez, Leticia Herrera Arellano, Alberto Villa Torres, Nayeli Acosta García, Dolores Aleman Quimbiulco, Sergio Armeaga Aguilar, Magdalena Madero
In December 2019, cases of acute respiratory illness of unknown origin were reported in Wuhan, China. The disease is caused by "severe acute respiratory syndrome coronavirus 2". After identifying severe lung damage, injury to other organs, such as the kidney, has been identified. Peritoneal dialysis is a renal replacement therapy (RRT) and is at least as effective as other extracorporeal therapy options, with significant cost-effective advantages. However, this strategy is rarely used for the management of acute kidney injury in severe lung disease...
2021: Blood Purification
https://read.qxmd.com/read/33037129/the-aftermath-of-aki-recurrent-aki-acute-kidney-disease-and-ckd-progression
#15
EDITORIAL
Yumeng Wen, Chirag R Parikh
No abstract text is available yet for this article.
January 2021: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/32784198/management-of-post-acute-covid-19-in-primary-care
#16
JOURNAL ARTICLE
Trisha Greenhalgh, Matthew Knight, Christine A'Court, Maria Buxton, Laiba Husain
No abstract text is available yet for this article.
August 11, 2020: BMJ: British Medical Journal
https://read.qxmd.com/read/32940785/causes-and-management-of-non-cirrhotic-portal-hypertension%C3%A2
#17
REVIEW
Stefania Gioia, Silvia Nardelli, Lorenzo Ridola, Oliviero Riggio
PURPOSE OF THE REVIEW: Non-cirrhotic portal hypertension (NCPH) includes a heterogeneous group of conditions. The aim of this paper is to make an overview on the denominations, diagnostical features and management of porto-sinusoidal vascular disease (PSVD) and chronic portal vein thrombosis (PVT) being the main causes of NCPH in the Western world. RECENT FINDINGS: The management of NCPH consists in the treatment of associated diseases and of portal hypertension (PH)...
September 17, 2020: Current Gastroenterology Reports
https://read.qxmd.com/read/32436307/hemodialysis-treatment-in-patients-with-severe-electrolyte-disorders-management-of-hyperkalemia-and-hyponatremia
#18
REVIEW
Markus Pirklbauer
Significant deviations of serum potassium and sodium levels are frequently observed in hospitalized patients and are both associated with increased all-cause and cardiovascular mortality. The presence of acute or chronic renal failure facilitates the pathogenesis and complicates the clinical management. In the absence of reliable outcome data in the context of dialysis prescription, requirement of renal replacement therapy in patients with severe electrolyte disturbances constitutes a therapeutic challenge...
July 2020: Hemodialysis International
https://read.qxmd.com/read/32423584/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo-controlled-multicentre-trial
#19
RANDOMIZED CONTROLLED TRIAL
Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu, Yi Hu, Guangwei Luo, Ke Wang, Yang Lu, Huadong Li, Shuzhen Wang, Shunan Ruan, Chengqing Yang, Chunlin Mei, Yi Wang, Dan Ding, Feng Wu, Xin Tang, Xianzhi Ye, Yingchun Ye, Bing Liu, Jie Yang, Wen Yin, Aili Wang, Guohui Fan, Fei Zhou, Zhibo Liu, Xiaoying Gu, Jiuyang Xu, Lianhan Shang, Yi Zhang, Lianjun Cao, Tingting Guo, Yan Wan, Hong Qin, Yushen Jiang, Thomas Jaki, Frederick G Hayden, Peter W Horby, Bin Cao, Chen Wang
BACKGROUND: No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside analogue prodrug, has inhibitory effects on pathogenic animal and human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro, and inhibits Middle East respiratory syndrome coronavirus, SARS-CoV-1, and SARS-CoV-2 replication in animal models. METHODS: We did a randomised, double-blind, placebo-controlled, multicentre trial at ten hospitals in Hubei, China...
May 16, 2020: Lancet
https://read.qxmd.com/read/32293205/diagnosis-and-detection-of-sarcoidosis-an-official-american-thoracic-society-clinical-practice-guideline
#20
JOURNAL ARTICLE
Elliott D Crouser, Lisa A Maier, Kevin C Wilson, Catherine A Bonham, Adam S Morgenthau, Karen C Patterson, Eric Abston, Richard C Bernstein, Ron Blankstein, Edward S Chen, Daniel A Culver, Wonder Drake, Marjolein Drent, Alicia K Gerke, Michael Ghobrial, Praveen Govender, Nabeel Hamzeh, W Ennis James, Marc A Judson, Liz Kellermeyer, Shandra Knight, Laura L Koth, Venerino Poletti, Subha V Raman, Melissa H Tukey, Gloria E Westney, Robert P Baughman
Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternative causes of granulomatous disease. There are no universally accepted measures to determine if each diagnostic criterion has been satisfied; therefore, the diagnosis of sarcoidosis is never fully secure. Methods: Systematic reviews and, when appropriate, meta-analyses were performed to summarize the best available evidence...
April 15, 2020: American Journal of Respiratory and Critical Care Medicine
label_collection
label_collection
5696
1
2
2020-05-25 12:39:36
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.